The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...

J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...

MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect ...

Ozempic contains the active ingredient, semaglutide, which helps regulate hunger signals.

The global rapid-acting insulin market is expected to grow at a CAGR of 4.75% and reach US$ 11.17 billion by 2032, from US$ 7.36 billion in 2023. The market is mainly driven by growth rate of diabetes ...

Drew, a 36-year-old man from San Antonio, Texas, drove more than 400 kilometres to Mexico to buy cheap Ozempic to help him lose weight. Going home, he checked the pens. They looked unusual, so he ...

As a health journalist, I’m doing my best to keep up with all things weight loss drugs, but with headlines rolling in every ...

The global insulin pens market is experiencing rapid expansion, driven by the rising global prevalence of diabetes. According ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE ... Tresiba’s excellent profile in the long-acting insulin market has not been enough to protect it from pricing ...